Search Results for: GLP-1
- Hot News
Lizzo and Serena Williams Break Silence Amid GLP-1 Drug Backlash—Here’s What They Said
The conversation around GLP-1 medications — a class of drugs originally developed for type 2 diabetes and now widely prescribed…
Read More » - Hot News
Study shows shift in GLP-1 drug use for obesity, not diabetes
According to a recent study, the primary intent of GLP-1 medications, such as Ozempic, was to treat Type 2 diabetes.…
Read More » - Food
Low Calorie Protein Shake Recipes for Weight Loss for Fast & Healthy Results
Losing weight doesn’t have to mean starving yourself or giving up on delicious food. In fact, one of the smartest…
Read More » - Food
Natural Mounjaro Recipe for Weight Loss: A Safe, Effective, and Affordable Alternative
In recent years, weight loss medications like Mounjaro have gained massive popularity for their ability to regulate appetite, stabilize blood…
Read More » - Hot News
Australia Sounds Alarm Over Mental Health Risks Linked to Popular Weight-Loss Drugs
Australia’s medicines regulator has moved to update safety information for a class of widely prescribed diabetes and weight-loss drugs, raising…
Read More » - Hot News
Eli Lilly Slashes Price of Top-Selling Weight-Loss Drug Zepbound
Eli Lilly on Monday announced a fresh price cut for Zepbound — its blockbuster tirzepatide-based weight-loss medicine — lowering the…
Read More » - Hot News
Post Malone’s Weight Loss Journey: What He’s Revealed About His Health
When Post Malone (Austin Post) began showing up at concerts and on social media noticeably slimmer than fans remembered, the…
Read More » - Hot News
Trump Strikes Major Deals with Eli Lilly and Novo Nordisk to Cut Weight-Loss Drug Costs
On November 6, 2025, the White House announced a landmark agreement with two of the world’s largest pharmaceutical companies —…
Read More » - Hot News
White House Set to Finalize Plan to Lower Prices for Weight Loss Drugs
A major shift in U.S. drug policy appears to be arriving at the doorstep of millions of Americans. In early…
Read More » - Hot News
Inside Novo’s $2.1 Billion Gamble on Omeros — What This Means for the Future of Medicine
On October 15, 2025, Novo Nordisk — the Danish pharmaceutical giant known globally for insulin and for turning GLP-1 drugs…
Read More »